logo
PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call

PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call

Yahoo10-06-2025
DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process.
The Company anticipates that it will issue the earnings release, hold the related conference call, and file its Annual Report on Form 10-K as soon as possible, but no later than June 16, 2025.
About PetMed Express, Inc.
Founded in 1996, PetMeds is a leader in pioneering the digital pet pharmacy industry. As a national online retailer, PetMeds.com and PetCareRx.com are top choices for delivering preventive and chronic symptom prescriptions and OTC medications and products through their thousands of veterinary partners and a loyal customer base. Leveraging telehealth and insurance partnerships, they offer value and convenience to pet families at every stage of their pets' lives, whether dogs, cats, or horses. PetMeds and PetCareRx provide a comprehensive range of medications, food products, and essential supplies through their websites, www.PetMeds.com and www.PetCareRx.com.
Investor Contact:
ICR, LLCJohn Mills(646) 277-1254Reed Anderson(646) 277-1260investor@petmeds.comSign in to access your portfolio
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US Tiger Securities Sticks to Its Buy Rating for XPeng, Inc. ADR (XPEV)
US Tiger Securities Sticks to Its Buy Rating for XPeng, Inc. ADR (XPEV)

Business Insider

time3 hours ago

  • Business Insider

US Tiger Securities Sticks to Its Buy Rating for XPeng, Inc. ADR (XPEV)

In a report released today, Bo Pei CFA from US Tiger Securities reiterated a Buy rating on XPeng, Inc. ADR, with a price target of $28.00. The company's shares closed today at $20.74. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Pei CFA is ranked #9697 out of 9921 analysts. In addition to US Tiger Securities, XPeng, Inc. ADR also received a Buy from Bank of America Securities's Ming-Hsun Lee in a report issued today. However, on August 11, Bernstein maintained a Hold rating on XPeng, Inc. ADR (NYSE: XPEV). The company has a one-year high of $27.16 and a one-year low of $6.65. Currently, XPeng, Inc. ADR has an average volume of 6.99M.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store